Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-19

Clinical Trial Update: Safety Study of 90Y-hMN14 to Treat Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for safety study of 90Y-hMN14 in colorectal cancer (Phase 1/Phase 2) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 90Y-hMN14 (90Y-hMN14)

Snippet

Sponsor: Gilead Sciences | Conditions: Colorectal Cancer, Colon Cancer | Phase 1, Phase 2 | Status: COMPLETED